Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Annual SHAM

Last year PTSC issued a press release on Dec 2 announcing that its annual shareholder meeting would be held on Feb 10. The proxy statement was filed Dec. 21

Perhaps a PR for the Markman will coincide with an announcement for the next annual shareholder meeting.

Share
New Message
Please login to post a reply